Literature DB >> 19776115

Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.

Eung-Soo Hwang1, Zhigang Zhang, Haobin Cai, David Y Huang, Shu-Mei Huong, Chang-Yong Cha, Eng-Shang Huang.   

Abstract

Infection of host cells with human cytomegalovirus (HCMV) induces cell cycle dysregulation. Two HCMV immediate-early (IE) proteins, IE1-72 and IE2-86, are promiscuous transactivators that have been implicated in the dysregulatory events. Cellular p53 protein is accumulated to high levels in HCMV-infected cells, but the indicative marker of p53 transcriptional activity, p21, is markedly decreased. Both IE1-72 and IE2-86 were able to transactivate the p53 promoter and interact with p53 protein in DNA-transfected or HCMV-infected cells. HCMV UL84, a multiregulatory protein expressed in early periods of HCMV infection, also interacted with p53. HCMV IE1-72 prevented or disrupted p53 binding to p53-specific DNA sequences, while IE2-86 and/or UL84 enhanced p53 binding and induced supershift of this DNA-protein complex. Both HCMV IE1-72 and IE2-86 were able to inhibit p53-dependent transcriptional activation in plasmid-transfected cells. IE1-72, rather than IE2-86, was found to be responsible for p21 downregulation in HCMV-infected HEL cells. DNA transfection analysis using IE1-72 mutants revealed that exon 2/3 and the zinc finger region of IE1-72 are essential for IE1-72's effect on the repression of p53-dependent transcriptional activation. These data suggest that HCMV IE1-72 and/or IE2-86 transactivates the p53 promoter and induces p53 accumulation, but HCMV IE1-72 represses the p53 transactivation activity by a unique binding hindrance mechanism different from that of IE2-86. Thus, various modes of viral IE proteins and p53 interactions might result in multiple outcomes, such as stimulation of cellular DNA synthesis, cell cycle progression and cell cycle arrest, and prevention of program cell death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776115      PMCID: PMC2786713          DOI: 10.1128/JVI.00304-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  Association of cytomegalovirus (CMV) infections with increased recipient mortality following transplantation.

Authors:  J A Light; D S Burke
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

2.  Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.

Authors:  M G Davis; S C Kenney; J Kamine; J S Pagano; E S Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Rearrangement of the p53 gene in human osteogenic sarcomas.

Authors:  H Masuda; C Miller; H P Koeffler; H Battifora; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Human cytomegalovirus. I. Purification and characterization of viral DNA.

Authors:  E S Huang; S T Chen; J S Pagano
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

5.  Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection.

Authors:  M W Wathen; M F Stinski
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

6.  HCMV IE2-mediated inhibition of HAT activity downregulates p53 function.

Authors:  Chih-Hung Hsu; Margaret D T Chang; Kang-Yu Tai; Yu-Ting Yang; Pei-Shan Wang; Chi-Ju Chen; Yan-Hsiung Wang; Sheng-Chung Lee; Cheng-Wen Wu; Li-Jung Juan
Journal:  EMBO J       Date:  2004-05-13       Impact factor: 11.598

7.  The putative zinc finger of the human cytomegalovirus IE2 86-kilodalton protein is dispensable for DNA binding and autorepression, thereby demarcating a concise core domain in the C terminus of the protein.

Authors:  Jasmin Asmar; Lüder Wiebusch; Matthias Truss; Christian Hagemeier
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  Inhibition of human cytomegalovirus replication by small interfering RNAs.

Authors:  Lüder Wiebusch; Matthias Truss; Christian Hagemeier
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

10.  Correlation between stimulation of host cell DNA synthesis by human cytomegalovirus and lack of expression of a subset of early virus genes.

Authors:  J M DeMarchi
Journal:  Virology       Date:  1983-09       Impact factor: 3.616

View more
  29 in total

1.  Human cytomegalovirus induces the endoplasmic reticulum chaperone BiP through increased transcription and activation of translation by using the BiP internal ribosome entry site.

Authors:  Nicholas J Buchkovich; Yongjun Yu; Francis J Pierciey; James C Alwine
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

Review 2.  Gastrointestinal malignancy and the microbiome.

Authors:  Maria T Abreu; Richard M Peek
Journal:  Gastroenterology       Date:  2014-01-07       Impact factor: 22.682

3.  Human cytomegalovirus IE2 86 and IE2 40 proteins differentially regulate UL84 protein expression posttranscriptionally in the absence of other viral gene products.

Authors:  Rebecca L Sanders; Deborah H Spector
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

4.  The essential role of guinea pig cytomegalovirus (GPCMV) IE1 and IE2 homologs in viral replication and IE1-mediated ND10 targeting.

Authors:  Julia Hornig; K Yeon Choi; Alistair McGregor
Journal:  Virology       Date:  2017-02-10       Impact factor: 3.616

5.  RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.

Authors:  E Xiaofei; Bradford M Stadler; Michelle Debatis; Shixia Wang; Shan Lu; Timothy F Kowalik
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

6.  Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection.

Authors:  John P Savaryn; Justin M Reitsma; Tarin M Bigley; Brian D Halligan; Zhikang Qian; Dong Yu; Scott S Terhune
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

7.  Murine Cytomegalovirus M25 Proteins Sequester the Tumor Suppressor Protein p53 in Nuclear Accumulations.

Authors:  Martina Dezeljin; Martin Messerle; Ivana Kutle; Katarzyna M Szymańska-de Wijs; Boris Bogdanow; Berislav Cuvalo; Lars Steinbrück; Stipan Jonjić; Karen Wagner; Rainer Niedenthal; Matthias Selbach; Lüder Wiebusch
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

8.  The retinoblastoma tumor suppressor promotes efficient human cytomegalovirus lytic replication.

Authors:  Halena R VanDeusen; Robert F Kalejta
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

9.  Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.

Authors:  Tarin M Bigley; Justin M Reitsma; Scott S Terhune
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

Review 10.  Overview of Human Cytomegalovirus Pathogenesis.

Authors:  Heather L Fulkerson; Maciej T Nogalski; Donna Collins-McMillen; Andrew D Yurochko
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.